Globus Medical (GMED) Convertible Debt (2023)
Globus Medical (GMED) reported Convertible Debt of $417.4 million for Q4 2023, up 1.87% quarter-over-quarter from $409.7 million in Q3 2023.
Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends
Globus Medical has reported Convertible Debt for 1 years, with the latest figure at $417.4 million in Q4 2023.
- For the quarter ending Q4 2023, Convertible Debt changed N/A year-over-year to $417.4 million; the trailing twelve-month figure through Dec 2023 stood at $417.4 million (changed N/A YoY), and the FY2023 full-year result was $417.4 million, changed N/A from the prior year.
- Convertible Debt for Q4 2023 stood at $417.4 million, up from $409.7 million in the prior quarter.
- The five-year high for Convertible Debt was $417.4 million in Q4 2023, with the low at $409.7 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.71 Bn | 10.08 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 417.40 Mn |
| Sep 30, 2023 | 409.72 Mn |